Tech Company Financing Transactions
Cara Therapeutics Funding Round
Cara Therapeutics closed a $19 million Series C financing round on 11/28/2006. Investors included Alta Partners and Ascent Venture Partners.
Transaction Overview
Company Name
Announced On
11/28/2006
Transaction Type
Venture Equity
Amount
$19,000,000
Round
Series C
Investors
Alta Partners (Ed Hurwitz)
Proceeds Purpose
Dr. Derek Chalmers, President & CEO of Cara Therapeutics said,
"Combined with cash already on-hand, this financing provides Cara with
operating capital through 2008 and provides the runway necessary to advance
our next two drug candidates into the clinic."
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
4 Stamford Plz. 107 Elm St. 9th Floor
Stamford, CT 06902
USA
Stamford, CT 06902
USA
Phone
Website
Email Address
Overview
Cara Therapeutics is a biotechnology company focused on developing therapeutics to treat diseases associated with pain and inflammation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Derek Chalmers
Chief Financial Officer
Mani Mohindru
Chief Scientific Officer
Michael Lewis
VP - General Counsel
Scott Terrillion
VP - Operations
Eric Vandal
VP - R & D
Frédérique Menzaghi
Browse more venture capital transactions:
Prev: 11/27/2006: CardioSpectra venture capital transaction
Next: 11/28/2006: Aesthetic Sciences venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs